Depreciation Segment Information - Medical Reportable Segment Member、親会社株主に帰属する四半期純利益、自己株式の取得による支出他2件
- 【期間】
| 年度 | Depreciation Segment Information - Medical Reportable Segment Member | 親会社株主に帰属する四半期純利益 | 自己株式の取得による支出 | 非支配持分 | 売上原価 |
|---|
| 2009/12 | - | | 99.8億 | | - | | - | | 2333億 | |
| 2010/12 | - | | 122億 | +22.1% | -43.5億 | | - | | 2642億 | +13.2% |
| 2011/12 | - | | 123億 | +1.2% | - | | - | | 2790億 | +5.6% |
| 2012/12 | - | | 141億 | +14.5% | - | | - | | 3077億 | +10.3% |
| 2013/12 | - | | 151億 | +6.5% | - | | - | | 3762億 | +22.3% |
| 2014/12 | - | | 178億 | +18.3% | - | | - | | 3973億 | +5.6% |
| 2015/12 | - | | 186億 | +4.2% | - | | - | | 3903億 | -1.8% |
| 2016/12 | - | | 183億 | -1.2% | - | | - | | 3772億 | -3.3% |
| 2017/12 | - | | 188億 | +2.3% | - | | - | | 4353億 | +15.4% |
| 2018/12 | - | | 188億 | +0% | - | | 8.18億 | | 4587億 | +5.4% |
| 2019/12 | - | | - | | - | | 32.6億 | +298.5% | - | |
| 2020/12 | - | | - | | - | | 19.9億 | -39.1% | - | |
| 2021/12 | - | | - | | - | | 20.3億 | +2.4% | - | |
| 2022/12 | - | | - | | - | | 2.12億 | -89.6% | - | |
| 2023/12 | - | | - | | - | | 13.7億 | +546.2% | - | |
